(c) 2024 PillSync.com

raloxifene hydrochloride 60 MG Oral Tablet

1 INDICATIONS AND USAGE Raloxifene hydrochloride tablet, USP is an estrogen agonist/antagonist indicated for: Treatment of osteoporosis in postmenopausal women. ( 1.1 ) 1.1 Treatment of Osteoporosis in Postmenopausal Women Raloxifene hydrochloride tablets, USP are indicated for the treatment of osteoporosis in postmenopausal women [see Clinical Studies ( 14.1 )].

Camber Pharmaceuticals Inc


4 years ago ROUND WHITE IG 256 raloxifene hydrochloride 60 MG Oral Tablet

ROUND WHITE IG 256

4 years ago ROUND WHITE IG 256 raloxifene hydrochloride 60 MG Oral Tablet

IG 256 ROUND WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied Raloxifene hydrochloride tablets, USP 60 mg are white film coated round biconvex, de-bossed with IG on one side and 256 on the other, Supplied in bottles of 30 (NDC 31722-256-30), bottle of 100 (31722-256-01) and bottle of 1000 (NDC 31722-256-10) 16.2 Storage and Handling Store at controlled room temperature, 20º to 25ºC (68º to 77ºF) [see USP Controlled Room temperature]. The USP defines controlled room temperature as a temperature maintained thermostatically that encompasses the usual and customary working environment of 20º to 25ºC (68º to 77ºF); that results in a mean kinetic temperature calculated to be not more than 25ºC; and that allows for excursions between 15º and 30ºC (59º and 86ºF) that are experienced in pharmacies, hospitals, and warehouses.


More pills like ROUND IG 256












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site